DARTMOUTH, NS, June 6, 2011 /CNW/ - (Ocean Nutrition Canada) - A recent
meta-analysis published in the British Journal of Nutrition found that
a minimum of 250 mg of Omega-3 EPA and DHA found in fish is required to
reduce the risk of some coronary heart diseases.
Researchers found that 250 mg of EPA/DHA was associated with a 35
percent reduction in the risk of sudden cardiac death. Researchers
also found a 16 percent decrease of non-fatal coronary events.
Statistics published by the American Heart Association (AHA) show that coronary heart disease (CHD) is the single leading
cause of death in America with 425,425 deaths in the United States in
2006, and 1,255,000 new and recurrent coronary attacks per year. AHA
also states that about 34 percent of people that experience a coronary
attack in a given year die from it.
Co-author of the paper, Harry Rice, PhD, VP of Regulatory & Scientific
Affairs for Global Organization for Omega-3 EPA/DHA (GOED) told NutraIngredients-USA that the results "Suggest that
250mg/day EPA and DHA should be considered a minimum, not an optimum,
level of consumption."
Rice continued "What is really novel about this meta-analysis is that
the data used were from subjects previously free of known coronary
heart disease; thus, the positive results provide further evidence of
the need for establishing a dietary reference intake (DRI) for the
long-chain omega-3 fatty acids."
Jon Getzinger, Chief Sales and Marketing Officer, Ocean Nutrition Canada
Limited said "As a co-sponsor of this study we felt this meta-analysis
was important to confirm the need for supplementation of Omega-3
EPA/DHA. These nutrients are essential to overall good health, and it
has been proven in study after study to have heart health benefits."
Jon Getzinger continued "The AHA estimates that in 2009 the cost of
cardiovascular disease and stroke in the United States was $475.3
billion. We hope that studies like this will convince regulatory
authorities world-wide that there is a need to recommend intake levels
to ensure the general population understands the need for these
essential nutrients, and the amounts that should be part of a daily
About Ocean Nutrition Canada Limited (ONC):
Ocean Nutrition Canada (ONC) is a privately held company, whose major
shareholder is Clearwater Fine Foods Incorporated. Clearwater Fine
Foods Incorporated is a diversified holding/investment company whose
significant holdings include a controlling interest in Clearwater
Seafood's Limited Partnership, the world's largest integrated shellfish
harvester and processor.
ONC is the world's largest supplier of Omega-3 EPA and DHA ingredients
from fish oil, marketed into the dietary supplement and food
manufacturing markets. To date MEG-3® ingredients have been included in
over 100 billion servings of food and supplement products worldwide.
For more information about ONC visit www.ocean-nutrition.com, and for information on the health benefits of MEG-3® ingredients
please visit www.meg-3.com.
Omega-3 is a family of essential fatty acids, including EPA
(eicosapentaenoic acid), DHA(docosahexaenoic acid), and ALA
(alpha-linolenic acid). Oily fish (such as sardines, anchovies,
mackerel, and salmon) are the major known natural sources of Omega-3
EPA/DHA. ALA is found in plants, such as flax and chia. It is important
to note that the majority of health benefits associated with Omega-3
have been attributed to EPA and DHA, not plant-based ALA. While the
body can convert ALA into EPA/DHA, it does so very inefficiently (less
than one percent), leading many nutrition experts to recommend that
consumers increase their EPA and DHA levels by consuming EPA and DHA
directly (rather than from plant-sourced ALA). Although Omega-3 EPA/DHA
is important to overall good health, the human body is not able to
produce sufficient quantities on its own, so supplementation is
required, either by eating oily fish or foods fortified with Omega-3
EPA/DHA, or by taking fish oil supplements.
SOURCE OCEAN NUTRITION CANADA LTD.
For further information:
Ocean Nutrition Canada Ltd.